We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Biohaven
BHVN
$2.04B
| $3.55M | 0.09% |
251,882
+225,036
| +838% | +$4.01M |
|
352
Franklin Resources
BEN
$16.9B
| $3.55M | 0.09% |
+148,786
| New | +$3.07M |
|
353
Abercrombie & Fitch
ANF
$4.52B
| $3.54M | 0.09% |
42,684
-17,336
| -29% | -$1.32M |
|
354
Madison Square Garden
MSGS
$9.52B
| $3.53M | 0.09% |
16,888
+14,958
| +775% | +$2.88M |
|
355
American Water Works
AWK
$27B
| $3.52M | 0.09% |
+25,272
| New | +$3.62M |
|
356
Atmos Energy
ATO
$29.9B
| $3.5M | 0.09% |
+22,719
| New | +$3.53M |
|
357
Canadian National Railway
CNI
$78.3B
| $3.49M | 0.09% |
+33,501
| New | +$3.41M |
|
|
AL
358
DELISTED
Air Lease Corp
AL
| $3.48M | 0.09% |
59,480
+53,940
| +974% | +$2.81M |
|
|
OKLO
359
Oklo
OKLO
$6.54B
| $3.48M | 0.09% |
+62,082
| New | +$2.39M |
|
360
Innospec
IOSP
$2.11B
| $3.47M | 0.08% |
+41,245
| New | +$3.61M |
|
|
EMBJ
361
Embraer S.A. ADS
EMBJ
$11.9B
| $3.43M | 0.08% |
60,259
+21,336
| +55% | +$1.01M |
|
362
Blackstone
BX
$103B
| $3.42M | 0.08% |
22,893
-69,109
| -75% | -$9.5M |
|
|
BOW
363
Bowhead Specialty Holdings
BOW
$1.05B
| $3.41M | 0.08% |
+90,929
| New | +$3.48M |
|
364
Veralto
VLTO
$24.2B
| $3.4M | 0.08% |
33,702
+31,615
| +1,515% | +$3.05M |
|
365
UiPath
PATH
$6.52B
| $3.39M | 0.08% |
+264,965
| New | +$3.18M |
|
366
Willis Towers Watson
WTW
$30.1B
| $3.39M | 0.08% |
+11,050
| New | +$3.43M |
|
367
LegalZoom.com
LZ
$1.44B
| $3.34M | 0.08% |
+374,910
| New | +$3.14M |
|
368
Kinetik
KNTK
$3.77B
| $3.34M | 0.08% |
+75,722
| New | +$3.32M |
|
369
RLI Corp
RLI
$6.03B
| $3.3M | 0.08% |
+45,682
| New | +$3.42M |
|
370
Old National Bancorp
ONB
$10.2B
| $3.29M | 0.08% |
154,299
+138,287
| +864% | +$2.86M |
|
371
Charter Communications
CHTR
$17.1B
| $3.28M | 0.08% |
8,031
+4,273
| +114% | +$1.64M |
|
372
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $3.27M | 0.08% |
+69,973
| New | +$2.86M |
|
|
SPR
373
DELISTED
Spirit AeroSystems
SPR
| $3.27M | 0.08% |
+85,762
| New | +$3.08M |
|
374
M/I Homes
MHO
$3.94B
| $3.26M | 0.08% |
+29,059
| New | +$3.16M |
|
375
West Pharmaceutical
WST
$23.5B
| $3.25M | 0.08% |
14,874
+6,676
| +81% | +$1.43M |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.